How to Enhance the Bioavailability of Poorly Soluble Compounds Using Lipid-Based Formulations
We respect your privacy, by clicking ‘Watch On Demand’ you agree to receive our e-newsletter, including information on Podcasts, Webinars, event discounts and online learning opportunities. For further information on how we process and monitor your personal data click here. You can unsubscribe at anytime.
The interest in lipids formulations, and research in this area, has grown dramatically in the last 5 years. In this webcast, Dr. Jeff Browne, Ph.D of Catalent Pharma Solutions, discusses why the Interest in Lipid-Based Formulation. As well as Lipid-Based Formulation Strategies for Poorly Soluble and Hydrophobic API’s and Mechanism of Bioavailability Improvement.
Afterward, Dr. Browne discusses three case studies of:
- Lipolyzing Solution Formulation Filled into a Softgel: Cinnarizine
- Lipolyzing Suspension Formulation Filled into a Softgel: NCE
- A SEDDS Formulation Filled into a Softgel: Cyclosporin A
Presenters:
Jeff Browne
Ph.D
Catalent Pharma Solutions
We respect your privacy, by clicking ‘Watch On Demand’ you agree to receive our e-newsletter, including information on Podcasts, Webinars, event discounts and online learning opportunities. For further information on how we process and monitor your personal data click here. You can unsubscribe at anytime.
